ກົມອາຫານ ແລະ ຢາ :: ກະຊວງສາທາລະນະສຸກ, ສປປລາວ ::

Items	Registration information
ID	1045
No	1045
Brand Name	DEFERASIROX GPO
Ingredients	DEFERASIROX 250 MG
Dosage Form	DISPERSIBLE TABLET
Primary Packaging	NYLON/ALU/PVC BLISTER
Storage	DO NOT STORE ABOVE 30C, STORE IN THE ORIGNAL CONTAINER
Shelf Life	2 YEARS
Pack Size	BOX OF 3 X 10'S
Dispensing Category	Prescription only
ATC Classification	V03AC03
Pharmaceutical Class	IRON CHELATING AGENT
Indications	TREATMENT OF CHRONIC IRON OVERLOAD DUE TO BLOOD TRANSFUSIONS IN ADULT AND PEDIATRIC PATIENTS (AGED 2 YEARS AND OVER). ALSO INDICATED FOR THE TREATMENT OF CHRONIC IRON OVERLOAD IN PATIENTS WITH NONTRANSFUSION-DEPENDENT THALASSEMIA SYNDROMS AGED 10 YEARS AND OLDER
Contraindications	CRCL LESS THAN 40 ML/MIN OR SERUM CREATININE GREATER THAN 2 TIMES THE AGE-APPROPRIATE ULN. POOR PERFORMANCE STATUS, HIGH RISK MYELODYSPLASTIC SYNDROMES, ADVANCED MALIGNANCIES, PLATELET COUNTS LESS THAN 50 X 10^19/L, KNOWN HYPERSENSITIVITY
Side Effects	ABDOMINALPAIN, DIARRHEA, NAUSEA,VOMITING, INCREASE IN SERUM CREATININE, RASH
Unit Price
EDL	No
Description	OFF WHITE, FLATE, ROUND, COMPRESSED TABLETS, ONE SIDE DEBOSEED WITH "D250" AND THE OTHER SIDE DEBOSSED WITH "GPO"
Note
License Owner	KARNYA VIENGNAKORN EXPORT-IMPORT
Manufacturer	THE GOVERNMENT PHARMACEUTICAL ORGANISATION
Country	THAILAND
Import Registration No	1A 7/61 (NG)
Import Registration Date	2018-02-05
Activity	CERTIFICATE RELEASED
Applied Date	2024-08-26
FDD Registration No	12 I 5163/21
FDD Registration Date	2024-09-10
Expiry Date	2029-09-09